No Data
No Data
Novo Nordisk Cuts Guidance as Copycat Versions of Ozempic Hit Sales
6-K: Report of foreign private issuer (related to financial reporting)
Express News | Watching Novo Nordisk: Hearing Novo Nordisk Head Of U.S. Operations Says We Fully Expect The FDA To Enforce The Ban On Drug Compounding; We Will Continue To Fight Against Unlawful Compounding
Stocks Rise Pre-Bell Amid Optimism Over US-China Trade Talks; Fed Rate Decision Looms
Novo Nordisk Investors Breathe Sigh of Relief Despite Guidance Hit From Copycat Drugs -- 2nd Update
Trending Stocks Today | NetClass Technology Shoots up 42.45% Pre-Market
Jeffy Invests : $Hims & Hers Health (HIMS.US)$
